Per the brand's own site, compounded medications dispensed through AbundRX "are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality." This is a different regulatory category from an FDA-approved branded product
Results Twenty-three patients have been included into the study
2024, Sep;10(17):e37115 Gmez-Delgado I, Lpez-Pastor AR, Gonzlez-Jimnez A, Ramos-Acosta C, Hernndez-Garate Y, Martnez-Micaelo N, et al
Semaglutide and tirzepatide may not be suitable for some, including: People with type 1 diabetes Patients with diabetic retinopathy Those with end-stage kidney disease requiring dialysis Anyone with an allergy to semaglutide/tirzepatide or their components Individuals who have had pancreatitis in the past Women who are pregnant or breastfeeding Those with a history of multiple endocrine neoplasia syndrome Patients currently experiencing diabetic ketoacidosis Individuals with a personal/family history of medullary thyroid carcinoma Persons younger than 18 Understanding Injectable Weight Loss Medications Both semaglutide and tirzepatide represent powerful tools for weight loss treatment in Palm Beach